Rivastigmine Mini-Tablet for Alzheimer's Disease

Clinical trial NCT06828289 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06828289
Sponsor: Peking University First Hospital
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Alzheimer's Disease

Start date: 2025-02-28
Primary completion: 2026-12-31
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.